<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-5V25M3PX</identifier><date>2014</date><creator>Pregelj, Peter</creator><relation>documents/doc/5/URN_NBN_SI_doc-5V25M3PX_001.pdf</relation><relation>documents/doc/5/URN_NBN_SI_doc-5V25M3PX_001.txt</relation><format format_type="issue">1</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 3-6</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">28102951</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-5V25M3PX</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="slv">farmacija</subject><subject language_type_id="eng">pharmacy</subject><subject language_type_id="slv">stranski učinki</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Starting antidepressants and evaluating effectiveness</title><title>Uvajanje in ocenjevanje učinkovitosti antidepresivov</title></Record>